Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for left-sided pancreatic cancer

J M Fabre1, S Houry, J C Manderscheid

  • 1Department of Digestive Surgery, Hôpital Saint Eloi, Montpellier, France.

The British Journal of Surgery
|August 1, 1996
PubMed
Summary

Pancreatic resection for cancer offers lower mortality than palliative bypass. Curative surgery is only suitable for small, localized tumors, with fewer than 10% of patients qualifying.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.

The British journal of surgery·2021
Same author

Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial.

The British journal of surgery·2021
Same author

Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study.

Surgical endoscopy·2021
Same author

Laparoscopic right partial adrenalectomy (with video).

Journal of visceral surgery·2020
Same author

Prospective, multicentric, comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass, 277 patients, 3 years follow-up.

Journal of visceral surgery·2019

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Oncology

Background:

  • Exocrine pancreatic cancer of the body or tail poses significant treatment challenges.
  • Surgical intervention strategies range from resection to palliative procedures.

Purpose of the Study:

  • To analyze the outcomes of different surgical approaches for exocrine pancreatic cancer.
  • To identify patient subgroups who benefit most from curative resection versus palliative surgery.

Main Methods:

  • Retrospective analysis of 590 patients with exocrine pancreatic cancer (body/tail) undergoing surgery between 1982-1988.
  • Comparison of outcomes (mortality, morbidity, survival) across three groups: pancreatic resection (128), palliative bypass (164), and exploratory laparotomy/splanchnicectomy (293).

Related Experiment Videos

Main Results:

  • Pancreatic resection showed a significantly lower mortality rate (9%) compared to palliative bypass (19%).
  • High mortality (>40%) observed in both groups for patients over 70 with organ failure.
  • Patients with metastases had a median survival of 3.4 months irrespective of treatment.
  • Only patients with small tumors (<4cm), no lymph node involvement, and no metastases significantly benefited from resection (1- and 3-year survival 38% and 12%).

Conclusions:

  • Curative pancreatic resection should be reserved for a small subset of patients (<10%) with localized tumors confined to the pancreas.
  • For most patients, pancreatic resection serves as a palliative procedure without significant survival improvement.
  • Palliative surgery should be limited to candidates for digestive bypass, with non-surgical palliation for others.